sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension
- 1 November 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 281 (5) , L1051-L1057
- https://doi.org/10.1152/ajplung.2001.281.5.l1051
Abstract
Utilizing aortopulmonary vascular graft placement, we established a lamb model of pulmonary hypertension that mimics congenital heart disease with increased pulmonary blood flow. We previously demonstrated that endothelial nitric oxide synthase (eNOS) is increased in lambs at age 4 wk. However, these lambs display a selective impairment of endothelium-dependent pulmonary vasodilation that is suggestive of a derangement downstream of NO release. Thus our objective was to characterize potential alterations in the expression and activity of soluble guanylate cyclase (sGC) and phosphodiesterase type 5 (PDE5) induced by increased pulmonary blood flow and pulmonary hypertension. Late-gestational fetal lambs (n = 10) underwent in utero placement of an aortopulmonary vascular graft (shunt). Western blotting analysis on lung tissue from 4-wk-old shunted lambs and age-matched controls showed that protein for both subunits of sGC was increased in shunted lamb lungs compared with age-matched controls. Similarly, cGMP levels were increased in shunted lamb lungs compared with age-matched controls. However, PDE5 expression and activity were also increased in shunted lambs. Thus although cGMP generation was increased, concomitant upregulation of PDE5 expression and activity may have (at least partially) limited and accounted for the impairment of endothelium-dependent pulmonary vasodilation in shunted lambs.Keywords
This publication has 30 references indexed in Scilit:
- Regulation of Myosin Phosphatase by a Specific Interaction with cGMP- Dependent Protein Kinase IαScience, 1999
- Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.Journal of Clinical Investigation, 1998
- Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs.Journal of Clinical Investigation, 1997
- Elevated plasma levels of atrial natriuretic peptide (ANP) as a possible aggravating agent in congestive heart failureMedical Hypotheses, 1989
- Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation.Journal of Clinical Investigation, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- High plasma concentration of the atrial natriuretic peptide (ANP) with suppressed aldosterone secretion in congestive heart failureThe American Journal of Cardiology, 1988
- Pulmonary vascular disease with congenital heart lesions: pathologic features and causes.Circulation, 1981
- Diagnosis and management of postoperative pulmonary hypertensive crisis.Circulation, 1979